Financial Support in an Underserved and Low-Income Population With Heart Failure

Last updated: July 5, 2025
Sponsor: University of Texas Southwestern Medical Center
Overall Status: Completed

Phase

N/A

Condition

Congestive Heart Failure

Hyponatremia

Heart Failure

Treatment

Financial Support

Clinical Study ID

NCT05928026
STU-2022-1033
  • Ages 18-80
  • All Genders

Study Summary

The goal of this clinical trial is to test whether financial support in the form of a one-time $500 stipend would improve medication adherence and quality of life in low-income, socially-needy patients with heart failure with reduced ejection fraction in the post-discharge setting. The main questions it aims to answer are:

  • Will financial support improve heart failure quality of life?

  • Will financial support improve medication adherence?

Participants will complete surveys on quality of life, social stress, and spending habits at their baseline visit. Participants will be randomly assigned to receive $500 at their baseline visit or $0 at their baseline visit. At their one month visit, quality of life and medication adherence will be assessed. These results will be compared between groups. The group that received $0 at their baseline visit will be provided $500 at their one-month visit and return for a two-month visit. At that visit, quality of life and medication adherence will be assessed. These results will be compared to their one-month results.

Researchers will compare the 1-month quality of life scores and medication adherence scores between the immediate financial support vs delayed financial support. Researchers will also compare 1-month vs 2-month quality of life and adherence data for participants who were randomized to the delayed financial support group.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age > 18

  • English speaking participants who completed SOCIAL-HF study surveys

  • Ejection Fraction <=40% and eligible for at least one component of GDMT

  • Has at least some difficulty paying monthly bills (Somewhat Difficult and VeryDifficult)

  • Annual household income <130% Federal Poverty Limit

  • Have at least two additional social needs based on the following domains:

  • Cost-related nonadherence

  • Food Insecurity

  • Housing Instability

  • Transportation Difficulty

  • Unemployment

  • Household Crowding: Person/Room Ratio >1

  • Rent Burden: Rent/Income Ratio >30%

  • Low social support

  • Interpersonal Violence

  • History of Discrimination

Exclusion

Exclusion Criteria:

  • Unwilling to return for 1 and 2-month follow-up visits.

  • Currently in jail or prison

  • Primary residence outside Dallas County

  • Legal Blindness

  • Systolic blood pressure <90 mmHg on screening

  • Contraindications or Intolerance all medications available for therapeutic drugmonitoring (metoprolol, losartan, lisinopril, valsartan, and spironolactone)

  • Unable to answer orientation questions.

Study Design

Total Participants: 153
Treatment Group(s): 1
Primary Treatment: Financial Support
Phase:
Study Start date:
June 09, 2023
Estimated Completion Date:
May 01, 2025

Connect with a study center

  • UT Southwestern Medical Center

    Dallas, Texas 75235
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.